Is Eli Lilly Heading Back to New Highs? Plus Lionsgate Looks to Tap the SPAC Market 1/9/24
Shares of Eli Lilly closed just off record highs as CEO David Ricks is set to make comments at the JP Morgan Health Care conference. Could what he says send the stock rocketing again? And will an Alzheimer’s treatment be its next big blockbuster? Plus Lionsgate set to spin off its studio business in a SPAC deal. Vice Chairman Michael Burns joins with the latest on that deal. Fast Money Disclaimer
Audio is streamed directly from the publisher (dts.podtrac.com) as published in their RSS feed. Play Podcasts does not host this file. Rights-holders can request removal through the copyright & takedown page.
Show Notes
Shares of Eli Lilly closed just off record highs as CEO David Ricks is set to make comments at the JP Morgan Health Care conference. Could what he says send the stock rocketing again? And will an Alzheimer’s treatment be its next big blockbuster? Plus Lionsgate set to spin off its studio business in a SPAC deal. Vice Chairman Michael Burns joins with the latest on that deal.
Hosted by Simplecast, an AdsWizz company. See pcm.adswizz.com for information about our collection and use of personal data for advertising.